This defect, which was also observed in IBD patients with IBD-associated CARD9 SNP, is partly due to the impaired ability of the Card9–/– microbiota to metabolize Trp into AhR ligands, such as indole derivatives [8]. This evidence concerns the gene CARD9 and inflammatory bowel disease.